ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma

被引:16
|
作者
Zhang, Quanli [1 ,2 ,3 ]
Zheng, Xiufen [1 ,2 ,3 ]
Sun, Qi [2 ]
Shi, Run [2 ,3 ]
Wang, Jie [2 ,3 ]
Zhu, Biqing [2 ,3 ]
Xu, Lin [1 ,2 ,3 ]
Zhang, Guangqin [1 ]
Ren, Binhui [2 ,3 ]
机构
[1] China Pharmaceut Univ, Dept Clin Pharm, Nanjing 210009, Jiangsu, Peoples R China
[2] Jiangsu Key Lab Mol & Translat Canc Res, Nanjing 210009, Jiangsu, Peoples R China
[3] Inst Affiliated Nanjing Med Univ, Dept Thorac Surg, Jiangsu Canc Hosp, Canc Inst Jiangsu Prov, Baiziting 42, Nanjing 210009, Jiangsu, Peoples R China
关键词
ZNF692; TCGA; Lung adenocarcinoma (LUAD); Cell metabolism; GENE-EXPRESSION; CANCER; AMPK; GROWTH;
D O I
10.1016/j.bbrc.2017.06.180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By analyzing The Cancer Genome Atlas (TCGA) datasets, we discovered that the zinc finger protein 692 (ZNF692) were over-expressed in Lung adenocarcinoma (LUAD) tissues compared to adjacent non-tumor tissues (P < 0.0001). In this study, we investigated the function of ZNF692 in the progression of LUAD. We found that ZNF692 knockdown inhibited LUAD cells proliferation, migration, and invasion both in vitro and in vivo. And LUAD cell apoptosis was induced following the down-regulation of ZNF692. Our results show that ZNF692 is over-expressed in LUAD tissues compared to adjacent normal tissues, and hyper-expression of ZNF692 in LUAD is an independent risk factor for worse overall survival in LUAD patients (HR: 8.800, 95%CI: 1.082-71.560, P = 0.042) by Tissue Microarray stain assay (TMA). GO analysis indicated that most genes were enriched in metabolic process which were associated highly with ZNF692 levels. Collectively, our results suggested that ZNF692 may serve as a potential oncogene and biomarker in LUAD by influencing cell metabolism. (C) 2017 Published by Elsevier Inc.
引用
收藏
页码:1189 / 1196
页数:8
相关论文
共 50 条
  • [1] ZNF692 Promotes the Progression of Colon Adenocarcinoma by Regulating HSF4 Expression
    Yang, Zhengpeng
    Wu, Hao
    Dai, Defu
    Yuan, Yufeng
    Shao, Xueqian
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (12) : 2601 - 2610
  • [2] ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway
    Chen, Hanmin
    Li, Yanmin
    Wu, Gengqing
    Zeng, Qingming
    Huang, Haibing
    Zhang, Guoxi
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [3] ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway
    Xing, Yanwei
    Ren, Shuo
    Ai, Lianjie
    Sun, Weidong
    Zhao, Zhiwei
    Jiang, Fengqi
    Zhu, Yuekun
    Piao, Daxun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (05) : 1691 - 1703
  • [4] ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway
    Hanmin Chen
    Yanmin Li
    Gengqing Wu
    Qingming Zeng
    Haibing Huang
    Guoxi Zhang
    European Journal of Medical Research, 29
  • [5] ZNF692, a novel nucleolar regulator in cancer
    Brown, Isabella N.
    Navarro, M. C. Lafita
    Hao, Yi-Heng
    Conacci-Sorrell, Maralice
    FASEB JOURNAL, 2022, 36
  • [6] ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma
    Wang, Haofei
    Zhao, Juping
    Xie, Xin
    Dai, Jun
    Xu, Danfeng
    Huang, Xin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 671 : 255 - 262
  • [7] ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway
    Zheng, Di
    Wei, Zhun
    Zhang, Chong
    Liu, Wenda
    Gong, Changtian
    Wu, Fei
    Guo, Weichun
    BIOLOGY DIRECT, 2024, 19 (01)
  • [8] ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway
    Liu, Yuming
    Zeng, Dehua
    Gao, Yunzhen
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [9] A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer
    Zhu, Biqing
    Pan, Yinpeng
    Zheng, Xiufen
    Zhang, Quanli
    Wu, Yaqin
    Luo, Jing
    Li, Qian
    Lu, Emei
    Xu, Lin
    Jin, Guangfu
    Ren, Binhui
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 396 - 407
  • [10] 高表达ZNF692是胃癌患者不良预后的预测因子
    高其忠
    刘芬
    高翔
    葛晓松
    南京医科大学学报(自然科学版), 2019, 39 (12) : 1747 - 1750